[1] Zheng XT, Zeng RC, Huang JY, et al. The use of the angiosome concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels[J]. Ann Vasc Surg, 2016, 32(1):41-49.
[2] Koyama A, Komori K, Otsuka R, et al. Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff[J]. J Vasc Surg, 2016, 63(5):1360-1370.
[3] Qi W, Li Q, Liew CW, et al. SHP1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.[J]. Diabetologia, 2017, 60(3):585-596.
[4] Goldstone RN, Mccormack MC, Goldstein RL, et al. Photochemical tissue passivation attenuates AV fistula intimal hyperplasia[J]. Ann Surg, 2016, 267(1):183-188.
[5] Boudaly S, Morin J, Berthier R, et al. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice[J]. Eur Cytokine Netw, 2016, 13(1):29-37.
[6] Li MO, Rudensky AY. T cell receptor signalling in the control of regulatory T cell differentiation and function.[J]. Nat Rev Immunol, 2016, 16(4):220-233.
[7] Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy[J]. Immunology, 2016, 148(1):13-21.
[8] Yang BH, Hagemann S, Mamareli P, et al. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.[J]. Mucosal Immunol, 2016, 9(2):444.
[9] Malchow S, Leventhal DS, Lee Ⅴ, et al. Aire enforces immune tolerance by directing autoreactive T cells into the regulatory T cell lineage[J]. Immunity, 2016, 44(5):1102-1113. [10]Tao JH, Cheng M, Tang JP, et al. Foxp3, regulatory T cell, and autoimmune diseases[J]. Inflammation, 2017, 40(1):328-339.
[11]Jeong-Su D, Anabelle Ⅴ, Osee SY, et al. An IL-27/Lag3 axis enhances Foxp3+regulatory T cell suppressive function and therapeutic efficacy[J]. Mucosal Immunol, 2016, 9(1):137-145.
[12]Esterházy D, Loschko J, London M, et al. Classical dendritic cells are required for dietary antigen-mediated peripheral regulatory T cell and tolerance induction[J]. Nat Immunol, 2016, 17(5):545-555.
[13]Kalekar LA, Schmiel SE, Nandiwada SL, et al. CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors[J]. Nat Immunol, 2016, 17(3):304-314.
[14]Huang ShL, Yang LX, Yang ShJ, et al. Role of ORAI1 in the balloon injury-induced rat carotid artery neointimal formation and the relationship between ORAI1 and sodium and calcium exchange 1[J]. Chinese J Cardiology, 2016, 44(11):968-972. (in Chinese)
黄世亮, 杨丽霞, 杨淑娟,等. ORAI1在损伤导致大鼠颈动脉新生内膜形成中的作用及其与钠钙交换体1的关系[J]. 中华心血管病杂志, 2016, 44(11):968-972.
[15]Erne P, Sudano Ⅰ, Resink TJ, et al. Interventional therapy for hypertension: back on track again [J] ? Crit Rev Clin Lab Sci, 2016, 54(1):18-25.
[16]Zheng XT, Zeng RC, Huang JY, et al. The use of the angiosome concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels [J]. Ann Vasc Surg, 2016, 32(1):41-49.
[17]He M, Wang C, Sun JH, et al. Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells[J]. Biochem Pharmacol, 2017, 137:51-60.
[18]Sun HJ,Zhao MX, Ren XS, et al. Salusin-β promotes vascular smooth muscle cell migration and Intimal hyperplasia after vascular injury via ROS/NFκB/MMP-9 pathway.[J]. Antioxid Redox Signal, 2016, 24(18):1045-1057.
[19]Marone G, Varricchi G, Loffredo S, et al. Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis[J]. Eur J Pharmacol, 2016, 778:146-151.
[20]Corliss BA, Azimi MS, Munson JM, et al. Macrophages: an inflammatory link between angiogenesis and lymphangiogenesis[J]. Microcirculation, 2016, 23(2):95-121.
[21]Zhang Z, Coutinho AE, Man TY, et al. Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis[J]. J Endocrinol, 2017, 234(3):291-299.
[22]Fortunel N, Hatzfeld JS, Monier M, et al. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-β type Ⅱ receptor in a short-term in vitro assay[J]. Stem Cells, 2010, 18(2):102-111.
[23]Desouza CV, Hamel FG, Keshore B, et al. Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction [J]. Diabetes, 2011, 60(4):1286-1294.
[24]Ozkok A, Aktas E, Yilmaz A, et al. Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients[J]. Clin Nephrol, 2013, 79(1):21-30.
|